2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
What External and Internal Drivers Are Contributing to the Growth of theInterventional Oncology Devices Market?
Key players in the interventional oncology devices market, such as Argon Medical, are honing in on technologies like tissue volume to boost diagnostic precision and the success of treatment in oncology procedures. The term ’tissue volume’ is representative of the quantity of biological tissue procured during biopsy procedure. Acquiring larger tissue volumes enables a more exhaustive analysis, thereby refining the exactness of the diagnoses and improving the planning of treatments. For instance, Argon Medical, a medical device company based in the US, introduced the SuperCore Advantage semi-automatic biopsy in June 2023. The SuperCore Advantage outperforms leading competitors by collecting up to 35% more samples, reducing the necessity of multiple passes in biopsies. This ability is indispensable for securing sufficient tissue samples for precise diagnosis.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3304&type=smp
#What is the Projected CAGR for the Interventional Oncology Devices Market Size from 2025 to 2034?
The market size of interventional oncology devices has seen substantial growth in past few years. The market is predicted to expand from $2.39 billion in 2024 to $2.52 billion in 2025 showing a compound annual growth rate (CAGR) of 5.3%. The historical growth period could be linked to factors such as the rise in the elderly population, an augmented prevalence of cancer, an escalation in pharmaceutical research and development expenditure, growth in healthcare spending, and an increase in the count of healthcare facilities.
The market for interventional oncology devices is projected to witness robust expansion in the coming years, increasing to $3.34 billion in 2029 with a compound annual growth rate (CAGR) of 7.3%. This projected expansion in the forecast period can be linked to a rising elderly population, growing preference for minimally invasive surgeries (MIS), escalated spending on research and development, increased healthcare expenditure, the vast potential in developing economies, and the heightened prevalence of cancer and chronic conditions. Looming trends within this forecast timeline include emphasis on the development of enhanced image-guided oncology devices, leveraging artificial intelligence to devise innovative devices, crafting novel embolic devices for improved oncology procedures, focusing on the application of robotics technology and partnerships with other corporations and research institutes for speeding up product innovation and development.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3304
Which Upcoming Market Trends and Innovations Are Set to Influence theInterventional Oncology Devices Market’s Path Forward?
Leading organizations are turning their attention to the implementation of robotics technology in interventional oncology devices to enhance efficiency. This robotic system combines image-guided planning and routing with the positioning of varied instruments to the required body section with superior precision and effectiveness. For example, Quantum Surgical’s Epione interventional oncology robotics platform received approval from the U.S. Food and Drug Administration in March 2022.
Who Are the Dominant Market Players Pushing the Boundaries of theInterventional Oncology Devices Market?
Major companies operating in the interventional oncology devices market include Boston Scientific Corporation, Terumo Corporation, Siemens Healthineers, Sirtex Medical Limited, Henlius, Viant Medical, AngioDynamics Inc., Pfizer, Steris Applied Sterilization Technologies, Dr.Reddys, CapeRay, Innovent Biologics, Novartis AG, Consonance, ABLbio, Adimmune, Heraeus Medical, Bioavlee, Mediceena International, Sinapi biomedical, Olympus, Freudenberg Medical, Hisun Pharma, Beijing ShuangLu Pharmaceuticals, Edwards LifeSciences Corp, Gulf Dent Trading, LifeTech Scientific Corporation, Biomerics, Medtronic plc, Dickinson & Company, 3M Company, DISA Vascular, Johnson & Johnson, Eurolab, Koninklijke Philips, Quantum SurgicalKyowa Hakko Kirin, Viatris, Nipro, Zimmer Biomet Holdings, Profound Medical, Gedeon Richter, Baxter, Ti-TaMED, Abbott Laboratories, Cook Medical LLC, Adavium Medical, Autocam Medical, Bio-Thera, Stryker, GE Healthcare, Sonic Healthcare, Medicem, HealthTronics, Bayer AG, Intuitive Surgical Inc, Aster DM Healthcare, Danaher Corporation, Varian Medical Systems Inc., Smileneo, EDAP TMS S.A, Fresenius Medical Care AG, China Regenerative Medicine International
Order Your Report Now For A Swift Delivery:
What Are the Core Segments of the Interventional Oncology Devices Market, and How Do They Contribute to Growth?
The interventional oncology devices market covered in this report is segmented –
1) By Product: Embolization Devices, Ablation Devices, Support Devices
2) By procedure: Thermal Tumor Ablation, Non-Thermal Tumor Ablation, Transcatheter Arterial Chemoembolization (TACE), Transcatheter Arterial Radioembolization (TARE), Selective Internal Radiation Therapy (SIRT), Transcatheter Arterial Embolization (TAE), Bland Embolization
3) By Cancer Type: Liver Cancer, Kidney Cancer, Lung Cancer, Bone Cancer, Other Cancer Types
Subsegments:
1) By Embolization Devices: Embolic Agents, Catheters For Embolization, Delivery Systems For Embolic Agents
2) By Ablation Devices: Radiofrequency Ablation Devices, Microwave Ablation Devices, Cryoablation Devices, Laser Ablation Devices
3) By Support Devices: Imaging Guidance Systems, Access Devices, Fluid Management Systems
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=3304&type=smp
What Regions Are Dominating the Interventional Oncology Devices Market Growth?
North America was the largest region in the interventional oncology devices market in 2024. Asia-Pacific was the second largest region in the global interventional oncology devices market report. The regions covered in the interventional oncology devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Browse Through More Reports Similar to the Global Interventional Oncology Devices Market 2025, By The Business Research Company:
Healthcare EDI Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/healthcare-edi-global-market-report
Preventive Healthcare Technologies And Services Global Market Report 2024
Healthcare Interoperability Solutions Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
